With Another Push From Eisai, Can Arena’s Belviq Be A Blockbuster?
This article was originally published in PharmAsia News
Executive Summary
The Japanese pharma has expanded its collaboration with Arena for the obesity treatment Belviq, but the drug is off to a slow start in a market full of non-starters.